Regulation of major histocompatibility complex class II gene expression on bovine bronchial epithelial cells

John R. Spurzem, Olmero Sacco, Giovanni A. Rossi, Joe D. Beckmann, Stephen I. Rennard

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Induction and increased expression of major histocompatibility complex (MHC) class II antigens in tissues that do not normally express class II antigens is thought to be important in the pathogenesis of allograft rejection and may also be important in the pathogenesis of obliterative bronchiolitis in lung allografts. We hypothesized that MHC antigen expression on bronchial epithelial cells, particularly MHC class II expression, is regulated by immune mediators in a manner similar to the regulation of antigen expression by lymphoid cells. With an in vitro system of bovine bronchial epithelial cells, we evaluated the effects of both a lymphokine-containing supernatant and recombinant tumor necrosis factor-α on MHC class II expression. Immunofluorescence and flow cytometry demonstrated markedly increased MHC class II surface antigen expression on the bronchial epithelial cells after exposure to the lymphokine-containing supernatant. Tumor necrosis factor-α had no effect on MHC class II surface antigen expression. Immunosuppressant drugs altered the cellular responses to lymphokines in a manner similar to that of lymphoid cells. Dexamethasone suppressed the induction of MHC class II antigens at both the surface antigen and messenger RNA transcript levels. Cyclosporine did not have a consistent effect on the surface expression of class II antigens, but it did inhibit the messenger RNA transcript levels. These suppressive effects have implications for the therapy of airway disorders associated with lung and bone marrow transplantation.

Original languageEnglish (US)
Pages (from-to)94-102
Number of pages9
JournalThe Journal of Laboratory and Clinical Medicine
Volume120
Issue number1
StatePublished - Jul 1992

Fingerprint

MHC Class II Genes
Histocompatibility Antigens Class II
Major Histocompatibility Complex
Gene expression
Lymphokines
Surface Antigens
Epithelial Cells
Gene Expression
Allografts
Tumor Necrosis Factor-alpha
Antigens
Messenger RNA
Flow cytometry
Immunosuppressive Agents
Dexamethasone
Cyclosporine
Bone
Lymphocytes
Lung
Bronchiolitis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Regulation of major histocompatibility complex class II gene expression on bovine bronchial epithelial cells. / Spurzem, John R.; Sacco, Olmero; Rossi, Giovanni A.; Beckmann, Joe D.; Rennard, Stephen I.

In: The Journal of Laboratory and Clinical Medicine, Vol. 120, No. 1, 07.1992, p. 94-102.

Research output: Contribution to journalArticle

Spurzem, John R. ; Sacco, Olmero ; Rossi, Giovanni A. ; Beckmann, Joe D. ; Rennard, Stephen I. / Regulation of major histocompatibility complex class II gene expression on bovine bronchial epithelial cells. In: The Journal of Laboratory and Clinical Medicine. 1992 ; Vol. 120, No. 1. pp. 94-102.
@article{f7a093b7e51d4d318ccc972197e9f7a2,
title = "Regulation of major histocompatibility complex class II gene expression on bovine bronchial epithelial cells",
abstract = "Induction and increased expression of major histocompatibility complex (MHC) class II antigens in tissues that do not normally express class II antigens is thought to be important in the pathogenesis of allograft rejection and may also be important in the pathogenesis of obliterative bronchiolitis in lung allografts. We hypothesized that MHC antigen expression on bronchial epithelial cells, particularly MHC class II expression, is regulated by immune mediators in a manner similar to the regulation of antigen expression by lymphoid cells. With an in vitro system of bovine bronchial epithelial cells, we evaluated the effects of both a lymphokine-containing supernatant and recombinant tumor necrosis factor-α on MHC class II expression. Immunofluorescence and flow cytometry demonstrated markedly increased MHC class II surface antigen expression on the bronchial epithelial cells after exposure to the lymphokine-containing supernatant. Tumor necrosis factor-α had no effect on MHC class II surface antigen expression. Immunosuppressant drugs altered the cellular responses to lymphokines in a manner similar to that of lymphoid cells. Dexamethasone suppressed the induction of MHC class II antigens at both the surface antigen and messenger RNA transcript levels. Cyclosporine did not have a consistent effect on the surface expression of class II antigens, but it did inhibit the messenger RNA transcript levels. These suppressive effects have implications for the therapy of airway disorders associated with lung and bone marrow transplantation.",
author = "Spurzem, {John R.} and Olmero Sacco and Rossi, {Giovanni A.} and Beckmann, {Joe D.} and Rennard, {Stephen I.}",
year = "1992",
month = "7",
language = "English (US)",
volume = "120",
pages = "94--102",
journal = "Translational Research",
issn = "1931-5244",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Regulation of major histocompatibility complex class II gene expression on bovine bronchial epithelial cells

AU - Spurzem, John R.

AU - Sacco, Olmero

AU - Rossi, Giovanni A.

AU - Beckmann, Joe D.

AU - Rennard, Stephen I.

PY - 1992/7

Y1 - 1992/7

N2 - Induction and increased expression of major histocompatibility complex (MHC) class II antigens in tissues that do not normally express class II antigens is thought to be important in the pathogenesis of allograft rejection and may also be important in the pathogenesis of obliterative bronchiolitis in lung allografts. We hypothesized that MHC antigen expression on bronchial epithelial cells, particularly MHC class II expression, is regulated by immune mediators in a manner similar to the regulation of antigen expression by lymphoid cells. With an in vitro system of bovine bronchial epithelial cells, we evaluated the effects of both a lymphokine-containing supernatant and recombinant tumor necrosis factor-α on MHC class II expression. Immunofluorescence and flow cytometry demonstrated markedly increased MHC class II surface antigen expression on the bronchial epithelial cells after exposure to the lymphokine-containing supernatant. Tumor necrosis factor-α had no effect on MHC class II surface antigen expression. Immunosuppressant drugs altered the cellular responses to lymphokines in a manner similar to that of lymphoid cells. Dexamethasone suppressed the induction of MHC class II antigens at both the surface antigen and messenger RNA transcript levels. Cyclosporine did not have a consistent effect on the surface expression of class II antigens, but it did inhibit the messenger RNA transcript levels. These suppressive effects have implications for the therapy of airway disorders associated with lung and bone marrow transplantation.

AB - Induction and increased expression of major histocompatibility complex (MHC) class II antigens in tissues that do not normally express class II antigens is thought to be important in the pathogenesis of allograft rejection and may also be important in the pathogenesis of obliterative bronchiolitis in lung allografts. We hypothesized that MHC antigen expression on bronchial epithelial cells, particularly MHC class II expression, is regulated by immune mediators in a manner similar to the regulation of antigen expression by lymphoid cells. With an in vitro system of bovine bronchial epithelial cells, we evaluated the effects of both a lymphokine-containing supernatant and recombinant tumor necrosis factor-α on MHC class II expression. Immunofluorescence and flow cytometry demonstrated markedly increased MHC class II surface antigen expression on the bronchial epithelial cells after exposure to the lymphokine-containing supernatant. Tumor necrosis factor-α had no effect on MHC class II surface antigen expression. Immunosuppressant drugs altered the cellular responses to lymphokines in a manner similar to that of lymphoid cells. Dexamethasone suppressed the induction of MHC class II antigens at both the surface antigen and messenger RNA transcript levels. Cyclosporine did not have a consistent effect on the surface expression of class II antigens, but it did inhibit the messenger RNA transcript levels. These suppressive effects have implications for the therapy of airway disorders associated with lung and bone marrow transplantation.

UR - http://www.scopus.com/inward/record.url?scp=0026776413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026776413&partnerID=8YFLogxK

M3 - Article

C2 - 1613333

AN - SCOPUS:0026776413

VL - 120

SP - 94

EP - 102

JO - Translational Research

JF - Translational Research

SN - 1931-5244

IS - 1

ER -